Director Robert Willett executed the sale of 2,148 shares of Cognex (NASDAQ:CGNX) via open-market disposition on Feb. 13, 2026, following an immediate option exercise; see SEC Form 4 filing.
|
Metric |
Value |
|---|---|
|
Shares sold (direct) |
2,148 |
|
Transaction value |
~$128,000 |
|
Post-transaction shares (direct) |
0 |
|
Post-transaction shares (indirect) |
15,804 |
|
Post-transaction value (direct ownership) |
~$0 |
Transaction value based on SEC Form 4 weighted average purchase price ($59.50); post-transaction value based on Feb. 13, 2026 market close ($58.79).
-
How did the sale impact Robert Willett’s overall equity exposure to Cognex?
While the transaction reduced his direct common stock holdings to zero, Mr. Willett maintains exposure through 15,804 shares held indirectly via the Willett Parkhill Investment Trust and a substantial pool of 1,477,706 vested options that remain exercisable. -
Was this transaction a direct sale or did it involve derivative mechanics?
The transaction was a derivative-based event, consisting of the exercise of 2,148 stock options immediately followed by the sale of an equivalent number of shares, consistent with liquidity management practices rather than a reduction in underlying economic exposure. -
What portion of Mr. Willett’s holdings did this sale represent and what capacity remains?
The sale accounted for 11.97% of Mr. Willett’s pre-transaction total holdings and 100% of his direct common stock position, with indirect holdings and large option balances providing ongoing capacity for future transactions. -
Does this transaction signal an exit or capacity-driven moderation in selling activity?
The disposition reflects the drawdown of available direct common shares, but with sizable derivative and indirect holdings remaining, Mr. Willett retains material exposure and the ability to increase or monetize equity interests in the future.
|
Metric |
Value |
|---|---|
|
Price (as of market close 2/13/26) |
$59.50 |
|
Revenue (TTM) |
$994.36 million |
|
Net income (TTM) |
$114.44 million |
|
1-year price change |
79.51% |
* 1-year performance calculated using Feb. 13, 2026 as the reference date.
-
Cognex offers machine vision systems, vision software, sensors, and image-based barcode readers for automation and inspection in manufacturing and logistics environments.
-
It generates revenue by selling proprietary hardware and software solutions.
-
The company serves customers in consumer electronics, automotive, pharmaceuticals, food and beverage, and other industrial sectors globally.
Cognex is a leading provider of machine vision products, enabling automation and quality control across diverse manufacturing and distribution industries. The company leverages advanced imaging and deep learning technologies to deliver high-precision inspection and identification solutions. Its established presence in key industrial verticals and focus on proprietary innovation underpin its competitive positioning in the automation technology market.
